NeoCOAST-2

Business news, market intelligence, and global industry analysis.

The Latest

Representative image of targeted protein degradation research as SK Life Science Labs presents new preclinical p300 and PRMT5 cancer data at AACR 2026.

Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight

Why Cerebras’ IPO filing looks less like a chip listing and more like an AI infrastructure wager

What Doximity (NYSE: DOCS) CFO resignation means for governance, capital allocation, and investor confidence

Lycra launches VintageFX fibre at Kingpins Amsterdam as denim makers chase vintage looks without fit failure

Lycra has spotted denim’s next problem, and VintageFX is its answer

FDA Nods Granules Pharmaceuticals' Generic Drug for Pulmonary Hypertension

AstraZeneca’s breakthrough in lung cancer treatment: Datopotamab deruxtecan achieves promising survival rates

AstraZeneca’s datopotamab deruxtecan (Dato-DXd), a cutting-edge TROP2-directed antibody-drug conjugate, has demonstrated encouraging overall survival results in the TROPION-Lung01…

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

September 9, 2024